Use of embolization of the middle meningeal artery in chronic subdural hematoma recurrence

Descripción del Articulo

Chronic subdural hematoma (CSDH) is a frequent neurosurgical condition, which may develop recurrence in up to 30% of all cases. Embolization of the middle meningeal artery (MMA) is an adjuvant management strategy for reducing recurrence, especially in patients with risk factors, and it has a low com...

Descripción completa

Detalles Bibliográficos
Autores: Vargas-Urbina, John F., Saal-Zapata, Giancarlo, Rodriguez-Varela, Rodolfo
Formato: artículo
Fecha de Publicación:2020
Institución:Colegio Médico del Perú
Repositorio:Acta Médica Peruana
Lenguaje:español
OAI Identifier:oai:ojs.pkp.sfu.ca:article/1825
Enlace del recurso:https://amp.cmp.org.pe/index.php/AMP/article/view/1825
Nivel de acceso:acceso abierto
Materia:Hematoma, subdural, chronic
Meningeal arteries
Embolization
Recurrence
Trephining
id REVCMP_c460f12abc6183985a877e8c6d047ea8
oai_identifier_str oai:ojs.pkp.sfu.ca:article/1825
network_acronym_str REVCMP
network_name_str Acta Médica Peruana
repository_id_str .
spelling Use of embolization of the middle meningeal artery in chronic subdural hematoma recurrenceUso de la embolización de la arteria meníngea media en recidiva de hematoma subdural crónicoVargas-Urbina, John F.Saal-Zapata, GiancarloRodriguez-Varela, RodolfoHematoma, subdural, chronicMeningeal arteriesEmbolizationRecurrenceTrephiningChronic subdural hematoma (CSDH) is a frequent neurosurgical condition, which may develop recurrence in up to 30% of all cases. Embolization of the middle meningeal artery (MMA) is an adjuvant management strategy for reducing recurrence, especially in patients with risk factors, and it has a low complication rate. We present the case of an 83-year old male with history of anticoagulation, who was admitted in a healthcare facility because of right hemiparesis, dysarthria and gait impairment, and he had been sick for one week. A trepanation and CSDH evacuation were uneventfully performed. One month later, the patient was brought back because of CSDH recurrence, so another trepanation and adequate CSDH evacuation were performed, followed by embolization of the ipsilateral MMA. A control assessment after two months revealed absenceof recurrence and neurological improvement. We conclude that MMA embolization was an efficacious adjuvant therapy aiming to reduce CSDH recurrence, and this procedure may be indicated in patients with risk factors for recurrence.El hematoma subdural crónico (HSDC) es una patología neuroquirúrgica frecuente, con una recurrencia de hasta el 30% de los casos. La embolización de la arteria meníngea media (AMM) es una estrategia de manejo adyuvante para disminuir la recidiva, especialmente en pacientes con factores de riesgo para recurrencia, y tiene una baja tasa de complicaciones. Presentamos el caso de un varón de 83 años con antecedente de anticoagulación, que es admitido en centro sanitario por presentar hemiparesia derecha, disartria y alteración de la marcha, con un tiempo de enfermedad de una semana. Se realizó trepanación y evacuación del HSDC sin complicaciones. Un mes después retornó por recidiva del HSDC, por lo que se realizó trepanación y evacuación adecuada del HSDC, seguida de embolización de la AMM ipsilateral. El control a los dos meses mostró ausencia de recidiva, con mejoría neurológica del paciente. Concluimos que la embolización de la AMM fue un tratamiento adyuvante eficaz para disminuir la recidiva del HSDC y podría estar indicada en pacientes con factores de riesgo asociados a la recurrencia.Colegio Médico del Perú2020-12-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://amp.cmp.org.pe/index.php/AMP/article/view/182510.35663/amp.2020.374.1825ACTA MEDICA PERUANA; Vol 37 No 4 (2020): October - DecemberACTA MEDICA PERUANA; Vol. 37 Núm. 4 (2020): Octubre-Diciembre1728-59171018-8800reponame:Acta Médica Peruanainstname:Colegio Médico del Perúinstacron:CMPspahttps://amp.cmp.org.pe/index.php/AMP/article/view/1825/1250Copyright (c) 2020 ACTA MEDICA PERUANAinfo:eu-repo/semantics/openAccessoai:ojs.pkp.sfu.ca:article/18252024-08-23T07:33:47Z
dc.title.none.fl_str_mv Use of embolization of the middle meningeal artery in chronic subdural hematoma recurrence
Uso de la embolización de la arteria meníngea media en recidiva de hematoma subdural crónico
title Use of embolization of the middle meningeal artery in chronic subdural hematoma recurrence
spellingShingle Use of embolization of the middle meningeal artery in chronic subdural hematoma recurrence
Vargas-Urbina, John F.
Hematoma, subdural, chronic
Meningeal arteries
Embolization
Recurrence
Trephining
title_short Use of embolization of the middle meningeal artery in chronic subdural hematoma recurrence
title_full Use of embolization of the middle meningeal artery in chronic subdural hematoma recurrence
title_fullStr Use of embolization of the middle meningeal artery in chronic subdural hematoma recurrence
title_full_unstemmed Use of embolization of the middle meningeal artery in chronic subdural hematoma recurrence
title_sort Use of embolization of the middle meningeal artery in chronic subdural hematoma recurrence
dc.creator.none.fl_str_mv Vargas-Urbina, John F.
Saal-Zapata, Giancarlo
Rodriguez-Varela, Rodolfo
author Vargas-Urbina, John F.
author_facet Vargas-Urbina, John F.
Saal-Zapata, Giancarlo
Rodriguez-Varela, Rodolfo
author_role author
author2 Saal-Zapata, Giancarlo
Rodriguez-Varela, Rodolfo
author2_role author
author
dc.subject.none.fl_str_mv Hematoma, subdural, chronic
Meningeal arteries
Embolization
Recurrence
Trephining
topic Hematoma, subdural, chronic
Meningeal arteries
Embolization
Recurrence
Trephining
description Chronic subdural hematoma (CSDH) is a frequent neurosurgical condition, which may develop recurrence in up to 30% of all cases. Embolization of the middle meningeal artery (MMA) is an adjuvant management strategy for reducing recurrence, especially in patients with risk factors, and it has a low complication rate. We present the case of an 83-year old male with history of anticoagulation, who was admitted in a healthcare facility because of right hemiparesis, dysarthria and gait impairment, and he had been sick for one week. A trepanation and CSDH evacuation were uneventfully performed. One month later, the patient was brought back because of CSDH recurrence, so another trepanation and adequate CSDH evacuation were performed, followed by embolization of the ipsilateral MMA. A control assessment after two months revealed absenceof recurrence and neurological improvement. We conclude that MMA embolization was an efficacious adjuvant therapy aiming to reduce CSDH recurrence, and this procedure may be indicated in patients with risk factors for recurrence.
publishDate 2020
dc.date.none.fl_str_mv 2020-12-30
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/1825
10.35663/amp.2020.374.1825
url https://amp.cmp.org.pe/index.php/AMP/article/view/1825
identifier_str_mv 10.35663/amp.2020.374.1825
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/1825/1250
dc.rights.none.fl_str_mv Copyright (c) 2020 ACTA MEDICA PERUANA
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 ACTA MEDICA PERUANA
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Colegio Médico del Perú
publisher.none.fl_str_mv Colegio Médico del Perú
dc.source.none.fl_str_mv ACTA MEDICA PERUANA; Vol 37 No 4 (2020): October - December
ACTA MEDICA PERUANA; Vol. 37 Núm. 4 (2020): Octubre-Diciembre
1728-5917
1018-8800
reponame:Acta Médica Peruana
instname:Colegio Médico del Perú
instacron:CMP
instname_str Colegio Médico del Perú
instacron_str CMP
institution CMP
reponame_str Acta Médica Peruana
collection Acta Médica Peruana
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1816075110853902336
score 13.941313
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).